Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-17-025622)

Filing Details

Accession Number:: 0001140361-17-025622
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-20 18:31:49
Reporting Period:: 2017-06-16

Filing Date:: 2017-06-20
Accepted Time:: 2017-06-20 18:31:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1247681	Bryan V Lawlis	C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-06-16	3,750	$38.59	19,660	No	4	M	Direct
Common Stock	Disposition	2017-06-16	3,750	$90.00	15,910	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy) Common Stock	Disposition	2017-06-16	3,750	$0.00	3,750	$38.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,250	2008-08-22	2018-05-21	No	4	M	Direct

Footnotes

Trade made pursuant to a 10b5-1 plan executed on May 9, 2017
All shares sold at the same price.
Reflects the number of stock options outstanding after the transaction from this specific stock option grant.